Tag: mFOLFIRINOX

No improved OS in pancreatic cancer after neoadjuvant mFOLFIRINOX

Presented By
Prof. Knut Labori, Oslo University Hospital, Norway
Trial
Phase 2, NorPACT-1
Conference
ASCO 2023
Type
Peer-reviewed article

2 August 2023 09:35

Borderline resectable pancreatic cancer: phase 2 results

Presented By
Prof. Matthew H. Katz, University of Texas MD Anderson Cancer Center, USA
Trial
Phase 2, Alliance A021501
Conference
ASCO GI 2021
Type
Peer-reviewed article

12 March 2021 11:12
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com